With over 0.44 million Vera Therapeutics Inc (VERA) shares trading Friday and a closing price of $18.95 on the day, the dollar volume was approximately $8.33 million. The shares have shown a positive half year performance of 11.87% and its price on 01/12/24 gained nearly 0.64%. Currently, there are 44.43M common shares owned by the public and among those 28.24M shares have been available to trade.
Insiders at the company have transacted a total of 30 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 27 of these insider trades were purchases, accounting for 4,803,643 shares. Insider sales of the common stock occurred on 3 occasions, with total insider shares sold totaling 8,190 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Shares of Vera Therapeutics Inc (NASDAQ: VERA) opened at $18.94, up $0.11 from a prior closing price of $18.83. The company’s stock has a 5-day price change of 22.02% and 82.21% over the past three months. VERA shares are trading 23.21% year to date (YTD), with the 12-month market performance up to 220.64% higher. It has a 12-month low price of $5.62 and touched a high of $20.23 over the same period. VERA has an average intraday trading volume of 558.74K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 17.05%, 34.31%, and 45.29% respectively.
Institutional ownership of Vera Therapeutics Inc (NASDAQ: VERA) shares accounts for 68.51% of the company’s 44.43M shares outstanding.
It has a market capitalization of $841.95M and a beta (3y monthly) value of 0.85. The earnings-per-share (ttm) stands at -$2.87. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.02% over the week and 7.19% over the month.
Analysts forecast that Vera Therapeutics Inc (VERA) will achieve an EPS of -$0.51 for the current quarter, -$0.53 for the next quarter and -$2.16 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.58 while analysts give the company a high EPS estimate of -$0.42. Comparatively, EPS for the current quarter was -$1.18 a year ago. Earnings per share for the fiscal year are expected to increase by 34.69%, and 1.38% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 10 brokerage firm advisors rate Vera Therapeutics Inc (VERA) as a “Strong Buy” at a consensus score of 1.30. Specifically, 8 Wall Street analysts polled rate the stock as a buy, while 1 of the 10 advise that investors “hold,” and 0 rated it as a “Sell.”
